| 67.78 Delayed Data As of 4:00pm ET |  +0.62 / +0.92%Today’s Change | 20.10 Today|||52-Week Range 300.00 | -3.91% Year-to-Date |
| Previous close | 67.16 |
| Today’s open | 67.15 |
| Day’s range | 67.01 - 69.50 |
| Volume | 1,249,935 |
| Average volume (3 months) | 2,527,547 |
| Market cap | $6.5B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -24.39% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +110.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 33.09 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRNAModerna Inc | +0.40 | +2.11% |
| NKTRNektar Therapeutics | +0.20 | +0.62% |
| NBIXNeurocrine Bioscienc... | -0.02 | -0.02% |
| TECHBio-Techne Corp | +1.85 | +0.96% |
| Next reporting date | May 29, 2019 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $43.1M |
| Annual profit (last year) | -$67.7M |
| Net profit margin | -157.02% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Brendan Kennedy |
Executive Vice President- Operations Greg Christopher |
Corporate headquarters Nanaimo, British Columbia |
